Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Konar Organics is an Indian pharmaceutical manufacturing company focused on active pharmaceutical ingredients (APIs), intermediates, and related pharmaceutical ingredients. The company was established in 1988, converted from a private company to a public limited company in 1994, and has operated manufacturing facilities in the Hyderabad region, including an antibiotics unit at Kazipally, Medak. Its website and third-party company profiles indicate commercial production of both human and veterinary drug substances, with examples including rafoxanide, closantel sodium, sertraline hydrochloride intermediates, and tramadol hydrochloride. Konar Organics appears to be an operating, unlisted company rather than a clinical-stage biotech developer, and publicly available information points to a manufacturing and supply business rather than an R&D-driven therapeutic pipeline. The company therefore fits best as a commercial small-molecule pharma/API supplier serving pharmaceutical customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Konar Organics.